PEG Virus Precipitation Kit ab102538 provides an easy, convenient and time-saving method to concentrate viruses without ultra-centrifugation.
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
Images
Publications
Filter by
- Journal of medical virology 95:e289522023Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication.Applications:Unspecified applicationReactive species:Unspecified reactive speciesJinyu Zhang,Yi Zhang,Sushant Khanal,Dechao Cao,Juan Zhao,Xindi Dang,Lam Ngoc Thao Nguyen,Madison Schank,Xiao Y Wu,Yong Jiang,Shunbin Ning,Ling Wang,Mohamed El Gazzar,Jonathan P Moorman,Haitao Guo,Zhi Q YaoPubMed 37455550
- Nature communications 13:69932022Ascertaining cells' synaptic connections and RNA expression simultaneously with barcoded rabies virus libraries.Applications:Unspecified applicationReactive species:Unspecified reactive speciesArpiar Saunders,Kee Wui Huang,Cassandra Vondrak,Christina Hughes,Karina Smolyar,Harsha Sen,Adrienne C Philson,James Nemesh,Alec Wysoker,Seva Kashin,Bernardo L Sabatini,Steven A McCarrollPubMed 36384944
- The EMBO journal 41:e1103722022TSG101 associates with PARP1 and is essential for PARylation and DNA damage-induced NF-κB activation.Applications:Unspecified applicationReactive species:Unspecified reactive speciesAhmet Buğra Tufan,Katina Lazarow,Marina Kolesnichenko,Anje Sporbert,Jens Peter von Kries,Claus ScheidereitPubMed 36124865
- The Journal of international medical research 50:30006052211047602022Potential role of HBV DNA-induced CD8 T cell apoptosis in patients with systemic lupus erythematosus and rheumatoid arthritis.Applications:Unspecified applicationReactive species:Unspecified reactive speciesZifeng Wang,Fen Wang,Haiyang Ma,Shujuan LvPubMed 35726595
- Bio-protocol 12:e43922022Production of Recombinant Hepatitis B virus (HBV) and Detection of HBV in Infected Human Liver Organoids.Applications:Unspecified applicationReactive species:Unspecified reactive speciesTanvir Hossain,Shahla Romal,Tokameh MahmoudiPubMed 35800100
- Bioengineering (Basel, Switzerland) 9:2022Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins.Applications:Unspecified applicationReactive species:Unspecified reactive speciesSeçkin Akgül,Carolin Offenhäuser,Anja Kordowski,Bryan W DayPubMed 35324780
- Molecular therapy : the journal of the American Society of Gene Therapy 30:1979-19932022Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.Applications:Unspecified applicationReactive species:Unspecified reactive speciesOlga Minenkova,Daniela Santapaola,Ferdinando Maria Milazzo,Anna Maria Anastasi,Gianfranco Battistuzzi,Caterina Chiapparino,Antonio Rosi,Giuseppe Gritti,Gianmaria Borleri,Alessandro Rambaldi,Clélia Dental,Cécile Viollet,Bruno Pagano,Laura Salvini,Emanuele Marra,Laura Luberto,Antonio Rossi,Anna Riccio,Emilio Merlo Pich,Maria Gabriella Santoro,Rita De SantisPubMed 35167974
- Biotechnology journal 16:e21001762021Surrogate model to screen for inactivation-based clearance of enveloped viruses during biotherapeutics process development.Applications:Unspecified applicationReactive species:Unspecified reactive speciesHasin Feroz,Daniel Cetnar,Robert Hewlett,Satish Sharma,Melissa Holstein,Sanchayita Ghose,Zheng Jian LiPubMed 34506679
- PLoS pathogens 17:e10098342021EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.Applications:Unspecified applicationReactive species:Unspecified reactive speciesChenhe Su,Fang Lu,Samantha S Soldan,R Jason Lamontagne,Hsin-Yao Tang,Giorgia Napoletani,Paul J Farrell,Italo Tempera,Andrew V Kossenkov,Paul M LiebermanPubMed 34352044
- eLife 10:2021Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.Applications:Unspecified applicationReactive species:Unspecified reactive speciesElisa De Crignis,Tanvir Hossain,Shahla Romal,Fabrizia Carofiglio,Panagiotis Moulos,Mir Mubashir Khalid,Shringar Rao,Ameneh Bazrafshan,Monique Ma Verstegen,Farzin Pourfarzad,Christina Koutsothanassis,Helmuth Gehart,Tsung Wai Kan,Robert-Jan Palstra,Charles Boucher,Jan Nm IJzermans,Meritxell Huch,Sylvia F Boj,Robert Vries,Hans Clevers,Luc Jw van der Laan,Pantelis Hatzis,Tokameh MahmoudiPubMed 34328417
Key facts
- Sample type
- Cell culture media, Other biological fluids
- Assay type
- Direct
- Range
- 40 - 100 %
- Sensitivity
- > 40 %
Target data
What's included?
Recommended products
PEG Virus Precipitation Kit ab102538 provides an easy, convenient and time-saving method to concentrate viruses without ultra-centrifugation.
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
Key facts
- Sample type
- Cell culture media, Other biological fluids
- Assay type
- Direct
- Range
- 40 - 100 %
- Sensitivity
- > 40 %
Storage
- Shipped at conditions
- Blue Ice
- Appropriate short-term storage conditions
- +4°C
- Appropriate long-term storage conditions
- +4°C
- Storage information
- -20°C
Notes
PEG Virus Precipitation Kit ab102538 provides an easy, convenient and time-saving method to concentrate viruses without ultra-centrifugation.
Viruses are usually produced at a low titer. They often need to be concentrated for storage or further applications. A quick, easy and inexpensive method is desired to concentrate viruses and remove impurities.
The PEG Virus Precipitation method is suitable for both small scale lab samples, and large scale virus preparations with high yield and high viral titer. It can be used to concentrate viruses including retroviruses, baculoviruses, lentiviruses, and phage, in cell culture medium and environmental samples. Viruses can be concentrated over 100 fold. The concentrated virus can be used for infection, viral DNA or RNA purification, etc.
An optimized Virus Re-suspension Solution is included in the kit to maximize viral recovery by 40-100% depending on the virus type and sources. The whole process uses non-toxic reagents.
This product was previously called K904 Biovision PEG Virus Precipitation Kit. Biovision was acquired by Abcam in 2021.
The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.
Product promise
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
1 product image
Functional Studies - PEG Virus Precipitation Kit (ab102538)
Concentration of baculovirus: Low titer baculovirus (10 ml) expressing human Granzyme B was precipitated following the kit protocol and the precipitate was suspended in 1 ml of Virus Re-suspension Solution. Both low titer and precipitated baculovirus was subsequently used to infect SF9 Insect cells. The activity of recombinant Granzyme B secreted into the culture medium by low titer and precipitated baculovirus infected insect cells was monitored using Granzyme B Activity Assay Kit (Fluorometric) ab157403 - Granzyme B Activity Assay Kit (Fluorometric).
Downloads
Product protocols
- Visit the general protocols
- Visit troubleshooting
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com